Cowen and Company’s Immunomedics Inc IMMU Stock Holding History

Cowen and Company’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-58,800	Closed	-$9K	–	655
2020 Q3	$9K	Buy	+58,800	New	+$2.97M	﹤0.01%	398
2020 Q1	–	Sell	-36,000	Closed	-$92K	–	598
2019 Q4	$92K	Sell	36,000 -174,000	-83%	-$3.07M	0.01%	271
2019 Q3	$95K	Buy	+210,000	New	+$3.09M	0.02%	294

Cowen and Company's IMMU Position: Q1 2020 in Review

Cowen and Company sold out of Immunomedics Inc (IMMU) in Q1 2020, closing a stake of 9,051 shares — an estimated $192K sold.

Cowen and Company first reported a position in IMMU in Q3 2019 and held it in 2 quarters. The position peaked at $504K in Q3 2019. 220 funds tracked by Wall St. Rank hold IMMU as of Q1 2020.

Cowen and Company reported no remaining Immunomedics Inc position as of Q1 2020 after selling out during the quarter.
Cowen and Company sold 9,051 Immunomedics Inc shares in Q1 2020, an estimated $192K.
Cowen and Company first reported a position in Immunomedics Inc in Q3 2019 and held it in 2 quarters.
Cowen and Company's Immunomedics Inc position peaked at $504K in Q3 2019.
220 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2020.

Based on Cowen and Company's 13F filing for Q1 2020, filed 11 May 2020.